Source: BioPortfolio

Implandata Ophthalmic: Implandata Successfully Gains CE Mark for its EYEMATE System for an Orphan Eye Indication

HANNOVER Germany April 29 2019 B3C newswire Ophthalmic sensors and digital health company Implandata Ophthalmic Products GmbH Implandata announced today that it successfully attained CE mark for its EYEMATE system for use in patients undergoing keratopr...

Read full article »
Implandata Ophthalmic's Competitors | Implandata Ophthalmic's News | Implandata Ophthalmic's Financials
Stay up-to-date with the latest news on Implandata Ophthalmic
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Max G. Ostermeier's photo - Co-Founder & CEO of Implandata Ophthalmic

Co-Founder & CEO

Max G. Ostermeier

CEO Approval Rating

79/100

Read more
Stay up-to-date with the latest news on Implandata Ophthalmic